Knowledge about AIDS and high-risk behavior among intravenous drug users in New York City.

PubWeight™: 1.47‹?› | Rank: Top 5%

🔗 View Article (PMID 3126773)

Published in AIDS on December 01, 1987

Authors

P A Selwyn1, C Feiner, C P Cox, C Lipshutz, R L Cohen

Author Affiliations

1: Montefiore Medical Center, Bronx, New York 10467.

Articles by these authors

Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med (1989) 4.72

WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci U S A (1998) 3.73

Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature (1998) 2.98

Gold determination in biological fluids by atomic absorption spectrophotometry: application to chrysotherapy in rheumatoid arthritis patients. Arthritis Rheum (1968) 2.74

Serologic studies of meningococcal infection and polysaccharide vaccination. J Infect Dis (1971) 2.54

Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer. Ann Intern Med (1997) 2.22

Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci U S A (1993) 1.82

Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals. AIDS (1994) 1.68

Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood (1996) 1.56

Moonlighting. JAMA (1990) 1.38

Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor. Cancer Invest (1998) 1.36

The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res (1994) 1.36

Meningococcal infections. 3. Studies of group A polysaccharide vaccines. Bull World Health Organ (1971) 1.23

Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells. Int J Cancer (1995) 1.23

Preliminary studies of an acid-labile factor (ALF) in human sera that inactivates platelet-activating factor (PAF). Clin Immunol Immunopathol (1980) 1.22

A noninvasive technique for measurement of changes in specific airway resistance. J Appl Physiol Respir Environ Exerc Physiol (1979) 1.21

Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factor. Fed Proc (1983) 1.16

Norepinephrine-mediated inhibition of antitumor cytotoxic T lymphocyte generation involves a beta-adrenergic receptor mechanism and decreased TNF-alpha gene expression. J Immunol (1999) 1.13

Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor. J Biol Chem (1994) 1.10

Effects of temperature on antimicrobial susceptibility of bacteria. J Infect Dis (1982) 1.10

Modified biochemical tests for characterization of L-phase variants of bacteria. Appl Microbiol (1968) 1.09

A cyanine dye distinguishes between cycling and non-cycling fibroblasts. Nature (1981) 1.07

Alopecia areata treated with topical minoxidil. Arch Dermatol (1984) 1.05

Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med (1997) 1.03

Research careers in child psychiatry: an update on five NIMH workshops. J Am Acad Child Adolesc Psychiatry (1990) 0.99

Frequency of GCH1 deletions in Dopa-responsive dystonia. J Neurol Neurosurg Psychiatry (2007) 0.97

A longitudinal study of aspartate aminotransferase in human gingival crevicular fluid. J Periodontal Res (1991) 0.95

Additional evidence for lack of transmission of HIV infection by close interpersonal (casual) contact. AIDS (1990) 0.95

Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer. Int J Cancer (1995) 0.94

Interaction of single-chain urokinase with its receptor induces the appearance and disappearance of binding epitopes within the resultant complex for other cell surface proteins. Blood (1996) 0.92

Substrate specificity and partial characterization of the PAF-acylhydrolase in human serum that rapidly inactivates platelet-activating factor. J Immunol (1986) 0.90

Ostensible versus actual reasons for seeking pediatric attention: another look at the parental ticket of admission. Pediatrics (1982) 0.89

The effect of encoding variables on the free recall of words and action events. Mem Cognit (1983) 0.89

Life-events and acceptance of pregnancy. J Psychosom Res (1968) 0.88

The incidence of nosocomial pneumonia following urgent endotracheal intubation. Infect Control (1987) 0.88

Maladaptation to pregnancy. Semin Perinatol (1979) 0.87

Demographic characteristics, drug use, and sexual behavior of i.v. drug user with AIDS in Bronx, New York. Public Health Rep (1991) 0.87

A cross-sectional analysis of aspartate aminotransferase in human gingival crevicular fluid. J Periodontal Res (1991) 0.86

Inhibition of lymphocyte activation by catecholamines: evidence for a non-classical mechanism of catecholamine action. Immunology (1995) 0.86

Hemagglutination inhibition for serogrouping of Neisseria meningitidis. Appl Microbiol (1972) 0.85

Interevent differences in event memory: why are some events more recallable than others? Mem Cognit (1987) 0.84

VIP elevates platelet cyclic AMP (cAMP) levels and inhibits in vitro platelet activation induced by platelet-activating factor (PAF). Peptides (1984) 0.84

Direct effects of minoxidil on epidermal cells in culture. J Invest Dermatol (1984) 0.83

Disseminated histoplasmosis, invasive pulmonary aspergillosis, and other opportunistic infections in a homosexual patient with acquired immune deficiency syndrome. Sex Transm Dis (1984) 0.83

Virulence of papillary endometrial carcinoma. Gynecol Oncol (1990) 0.82

A multi-center clinical trial of a new chairside test in distinguishing between diseased and healthy periodontal sites. II. Association between site type and test outcome before and after therapy. J Periodontol (1996) 0.81

Aspartate aminotransferase increases in crevicular fluid during experimental periodontitis in beagle dogs. J Periodontol (1984) 0.81

The presence of platelet-activating factor (PAF) in normal human mixed saliva. J Immunol (1981) 0.81

Neuroimmune modulation: signal transduction and catecholamines. Neurochem Int (1993) 0.81

Enhancement of the enzymatic activity of single-chain urokinase plasminogen activator by soluble urokinase receptor. J Biol Chem (1995) 0.80

In vivo immunomodulation by peripheral adrenergic and cholinergic agonists/antagonists in rat and mouse models. Ann N Y Acad Sci (2000) 0.80

Anaesthesia and cognitive functioning. Mental function in postoperative day patients at the time of their release. Anaesthesia (1982) 0.80

Thy-1+ epidermal cells are not demonstrable in rat and human skin. J Invest Dermatol (1986) 0.80

Immunologic detection of the cellular receptor for urokinase plasminogen activator. Clin Immunol Immunopathol (1994) 0.80

Neurotransmitter suppression of the in vitro generation of a cytotoxic T lymphocyte response against the syngeneic MOPC-315 plasmacytoma. Cancer Immunol Immunother (1995) 0.80

Statistical procedures for bioassays when the condition of similarity does not obtain. J Pharm Sci (1966) 0.80

Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes. Exp Cell Res (1998) 0.79

Circulating thrombopoietin concentrations in thrombocytopenic patients, including cancer patients following chemotherapy, with or without peripheral blood progenitor cell transplantation. Br J Haematol (1996) 0.79

Factors influencing maternal choice of childbirth alternatives. J Am Acad Child Psychiatry (1981) 0.78

Effect of tolbutamide and phenformin on lipolysis in adipose tissue in vitro. Am J Physiol (1966) 0.78

Heterogeneity of epidermal cells detected by the presence of Thy-1 antigen in athymic (nude) and normal Balb/c mice. Exp Cell Biol (1984) 0.78

Both pro-uPA and uPA: PAI-1 complex bind to the alpha 2-macroglobulin receptor/LDL receptor-related protein. Evidence for multiple independent contacts between the ligands and receptor. Ann N Y Acad Sci (1994) 0.78

A nonradioactive assay for type IV collagen degradation. Anal Biochem (1990) 0.78

Prophylaxis with cefamandole nafate in elective orthopedic surgery. Clin Orthop Relat Res (1986) 0.78

Adaptation effects and after effects of moving patterns viewed in the periphery of the visual field. Scand J Psychol (1965) 0.78

Hematocrit levels in breast-fed American babies. A preliminary study suggesting that nutritional anemia may not develop. Clin Pediatr (Phila) (1977) 0.77

Effects of CV-3988, an antagonist of platelet-activating factor (PAF), on washed rabbit platelets. Thromb Res (1986) 0.77

Failure of the urinalysis and quantitative urine culture in diagnosing symptomatic urinary tract infections in patients with long-term urinary catheters. Am J Infect Control (1985) 0.77

The dialogue between the brain and immune system involves not only the HPA-axis. Z Rheumatol (2000) 0.77

The effects of interference tasks on recency in the free recall of action events. Psychol Res (1989) 0.77

On the generality of the short-term memory/reading ability relationship. J Learn Disabil (1984) 0.77

Thrombin increases expression of urokinase receptor by activation of the thrombin receptor. Invest Ophthalmol Vis Sci (1995) 0.77

Hydrogen storage materials: properties and possibilities. Science (1981) 0.76

Thrombopoietin in the thrombocytopenic term and preterm newborn. Pediatrics (2000) 0.76

A prospective longitudinal study of neuropsychological and psychosocial factors in asymptomatic individuals at risk for HTLV-III/LAV infection in a methadone program: preliminary findings. Int J Neurosci (1987) 0.76

Clinical perspectives on premature tooth eruption and cyst formation in neonates. Pediatr Dermatol (1984) 0.76

Thrombopoietin mobilizes CD34+ cell subsets into peripheral blood and expands multilineage progenitors in bone marrow of cancer patients with normal hematopoiesis. Exp Hematol (1998) 0.76

Pharmacologic characterization of the rabbit neutrophil receptor for platelet-activating factor. Proc Soc Exp Biol Med (1990) 0.76

Simplified computation of confidence intervals for relative potencies using Fieller's theorem. J Pharm Sci (1966) 0.76

Molecular characterization of plasminogen activators in human gingival crevicular fluid. Arch Oral Biol (1995) 0.76

Effects of retinoic acid on plasminogen activators in murine epidermal cell culture. Ann N Y Acad Sci (1992) 0.76

A prospective comparison of neuropsychologic function in HIV-seropositive and seronegative methadone-maintained patients. AIDS (1990) 0.75

Outcome of subsequent pregnancies following antibiotic therapy after primary or multiple spontaneous abortions. Surg Gynecol Obstet (1986) 0.75

Life, death, and AIDS. Ann Intern Med (1999) 0.75

Loss measurements in optical fibers. 1: sensitivity limit of bolometric techniques. Appl Opt (1974) 0.75

Population Increase of Pratylenchus hexincisus on Corn as Related to Soil Temperature and Type. J Nematol (1980) 0.75

Parastomal hernia causing anuria; unusual complication of ileal conduit diversion. Urology (1974) 0.75

Noise in fiber optics communications systems induced by ionizing radiation. Appl Opt (1974) 0.75

Respiratory hypersensitivity to Ascaris extract in guinea pigs sensitized by aerosol. Int Arch Allergy Appl Immunol (1980) 0.75

Studies of the paw test and tumor-associated immunosuppression in mice. Int Arch Allergy Appl Immunol (1978) 0.75

The impact of a community mental health program on the operation of a university child guidance center. J Am Acad Child Psychiatry (1975) 0.75

Loss measurements in optical fibers. 2: bolometric measuring instrumentation. Appl Opt (1974) 0.75

On estimating relative potency from quadratic log-dose response relationships. Biometrics (1972) 0.75

Experiences in the alteration of sequence in child psychiatric training. J Am Acad Child Psychiatry (1973) 0.75

Herceptin: breaking new ground. Cancer Biother Radiopharm (1999) 0.75

Some maladaptive syndromes of pregnancy and the puerperium. Obstet Gynecol (1966) 0.75

Use of low-pass noise in word-recognition testing. J Speech Hear Res (1976) 0.75

Self-presentation, embarrassment, and facework as a function of self-evaluation, conditions of self-presentation, and feedback from others. J Pers Soc Psychol (1971) 0.75

Mössbauer spectroscopy: recent developments. Science (1972) 0.75